Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT01368081 · COMPLETED
Trial details
- NCT number
- NCT01368081
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-04-01
- Enrollment
- 1162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.